Experimental Dengue Virus Challenge of Human Subjects Previously Vaccinated with Live-Attenuated Tetravalent Dengue Virus Vaccines
The Journal of Infectious Diseases, 12/24/2012Sun W et al.
Protection against dengue requires immunity against all 4 serotypes of virus. Experimental challenge may be useful in evaluating vaccine–induced immunity. Vaccination with live–attenuated TDV induced variable protection against s.c. challenge. DENV–3 experimental challenge was associated with transient but significant hepatitis.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.